P39 Real world experience of using bezafibrate for PBC
Sign Up to like & getrecommendations! Published in 2020 at "Gut"
DOI: 10.1136/gutjnl-2020-basl.49
Abstract: Primary Biliary Cholangitis (PBC) is a rare autoimmune condition with an incidence of 20–40 cases per 100,000. Levels of alkaline phosphatase (ALP) can be used as a surrogate marker of clinical response to pharmacotherapy. Ursodeoxycholic… read more here.
Keywords: therapy; bezafibrate; bzf; real world ... See more keywords